Angelini Pharma
    • Who we are
    • Vision, purpose & values
    • Production Plants
    • People
      • Leadership Team
    • Key Financials
    • Brain Health
      • Mental Health
      • Epilepsy
    • Specialty and Primary care
    • Consumer Health
    • Science & Innovation
    • Clinical Trials
    • Research collaborations
    • Independent Research (IIT/RIS)
    • Licensing Out
    • Sustainability
    • Diversity & Inclusion
    • Ethics
    • Transparency
    • Quality and EHS
    • News
    • Press releases
    • Media Resources
  • Career
    • Austria
    • Bulgaria
    • Czech Republic
    • France
    • Germany
    • Greece
    • Hungary
    • Italy
    • Nordics
    • Poland
    • Portugal
    • Romania
    • Russia
    • Slovakia
    • Spain
    • Switzerland
    • Turkey
    • United Kingdom
    • United States
  1. Angelini Pharma
  2. Our responsibility
  3. Transparency
  4. Belgium

Belgium

Angelini Pharma France SAS has fulfilled legal reporting obligations per local requirements. Disclosures are available at the link: https://betransparent.be/fr/recherche/.

Inquiries may be submitted to frabenetransparency@angelinipharma.com

  • Privacy
  • Cookie Policy
  • Terms of use
  • Accessibility declaration
  • Webscraping
  • Transparency
  • Contact
  • Site map
  • Credits
  • Cookie settings
  • Top Employer Europe 2025
  • X
  • Linkedin
  • Instagram

Angelini Pharma S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Back to top